SARS-CoV-2 mRNA vaccine PTX-COVID19-B safe and highly immunogenic in preclinical study

Retrieved on: 2021-05-19 03:45:00

Tags for this article:

Click the tags to see associated articles and topics

SARS-CoV-2 mRNA vaccine PTX-COVID19-B safe and highly immunogenic in preclinical study. View article details on hiswai:

Excerpt

Researchers from Canada recently reported the pre-clinical development of PTX-COVID19-B, a lipid nanoparticle (LNP) formulated SARS-CoV-2 mRNA ...

Article found on: www.news-medical.net